Rankings
▼
Calendar
BCRX Q1 2018 Earnings — BioCryst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
BCRX
BioCryst Pharmaceuticals, Inc.
$2B
Q1 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$4M
-57.9% YoY
Gross Profit
$4M
96.5% margin
Operating Income
-$22M
-558.7% margin
Net Income
-$26M
-648.3% margin
EPS (Diluted)
$-0.26
QoQ Revenue Growth
+2.2%
Cash Flow
Operating Cash Flow
-$20M
Free Cash Flow
-$20M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$155M
Total Liabilities
$93M
Stockholders' Equity
$62M
Cash & Equivalents
$44M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4M
$9M
-57.9%
Gross Profit
$4M
$9M
-58.0%
Operating Income
-$22M
-$11M
-107.9%
Net Income
-$26M
-$14M
-81.3%
Revenue Segments
Royalty
$4M
92%
Collaborative and Other Research and Development
$315,000
8%
← FY 2018
All Quarters
Q2 2018 →